Catalog Advanced Search
-
Contains 1 Component(s) Includes a Live Web Event on 10/28/2026 at 12:00 PM (CDT)
Join us to explore how AI can be applied responsibly throughout the case review process. Discover which tasks can be automated, where human expertise delivers the greatest value, and how to achieve the right balance between efficiency and scientific oversight.
As next-generation sequencing (NGS) becomes the standard of care, a laboratory's competitive advantage is no longer defined by the test itself, but by how effectively it leverages data, automation, and innovation. Laboratories that embrace AI, invest in scalable data infrastructure, and integrate intelligent workflows are better positioned to increase efficiency, expand testing capacity, and contribute to learning health systems.
Join us to explore how AI can be applied responsibly throughout the case review process. Discover which tasks can be automated, where human expertise delivers the greatest value, and how to achieve the right balance between efficiency and scientific oversight.
Presented by:
NSGC Genomic Technologies SIG
1. Talia Silver, MHScLearning Objectives:
1. Explain the technical layer of genomics lab operations.
2. Explain different forms of AI, where and how they can be used, and what guardrails can enable safe adoption in a lab setting.
3. Explain how automation, and utilization of software stand to improve lab operations.
4. Explain how structured data storage enables reanalysis and research and what it can enable for healthcare systems.-
Register
- Non-member - $50
- Member - Free!
- More Information
-
Register
-
Contains 1 Component(s) Includes a Live Web Event on 10/21/2026 at 12:00 PM (CDT)
Learn a brief overview of what to expect at the Annual Conference and how to get the most out of your conference experience.
First-time attendees of the NSGC Annual Conference are invited to join this webinar for an overview of what to expect at the NSGC 45th Annual Conference. Learn more about NSGC membership benefits and programming, receive an overview of sessions to look forward to at this year's conference, and hear from recent graduates about their experience from attending the conference in the past. There will be time for Q&A at the end of the webinar.
This event is exclusively for Annual Conference attendees who have registered to attend the First-Time Attendee Workshop and/or the First-Time Attendee Welcome Reception on Tuesday, Nov. 10.
-
Register
- Non-member - Free!
- Member - Free!
- More Information
-
Register
-
Contains 1 Component(s) Includes a Live Web Event on 10/14/2026 at 12:00 PM (CDT)
This session pulls back the curtain on modern genetic testing laboratories, mapping out the lifecycle of a sample from initial accessioning to complex variant classification and reporting.
This session pulls back the curtain on modern genetic testing laboratories, mapping out the lifecycle of a sample from initial accessioning to complex variant classification and reporting. Panelists will demystify the operational, regulatory, and business constraints that shape lab policies, explaining the root causes behind turnaround times and reporting limitations. By addressing the perspective gap between clinic and laboratory, attendees will learn practical strategies to troubleshoot common delays and collaborate effectively with lab genetic counselors for better patient care.
Presented by:
NSGC Lab/Industry SIG
1. Matt Tschirgi, MS, CGC
2. Elizabeth Kramer Dugan, MGC, CGC
3. Elysia Pagano, MGC, CGCLearning Objectives:
1. Evaluate the operational, business, and cross-functional drivers behind genetic testing laboratory decisions, business metrics, and turnaround times.
2. Trace the journey of a sample through accessioning, triage, automation, and reporting.
3. Identify factors that impact testing capacity and workflow limitations.
4. Analyze the root causes of discrepancy between clinical expectations and lab capabilities, including requisition requirements, variant classification constraints, and reporting policies.
5. Apply practical communication strategies and best practices—such as providing detailed phenotype data and engaging effectively with lab genetic counselors—to streamline case management and optimize patient outcomes.$i++ ?>Elysia Pagano, MGC, CGC
Certified Genetic Counselor
Elysia is a board-certified genetic counselor and Senior Marketing Manager at Natera. She received her Master's in Genetic Counseling from the University of Maryland in Baltimore. In her role as a clinician, Elysia provided genetic counseling services for patients in high-volume maternal-fetal medicine clinics for about 10 years. As an educator, Elysia has been involved in didactic and clinical teaching of a variety of learners, including medical students, residents, and fellows, as well as genetic counseling students. Elysia has enjoyed a number leadership roles in professional committees with the NSGC, the ABGC, and the ACGC.
$i++ ?>Elizabeth Kramer Dugan, MGC, CGC
Certified Genetic Counselor
Elizabeth holds a Masters in Genetic Counseling from the University of Maryland School of Medicine and a B.A in English and Biology from Georgetown University. Elizabeth has over 20 years of genetic counseling experience in both clinical practice and laboratory settings. She has also authored or co-authored numerous publications and conference presentations on prenatal diagnostics. Elizabeth’s professional interests include prenatal genetics, education and multi-state licensure.
$i++ ?>Matt Tschirgi, MS, CGC
Certified Genetic Counselor
Matt Tschirgi earned his BS degree from Washington State University, and his MS degree in genetic counseling from University of Texas Health Science Center at Houston. He has more than 25 years combined experience in clinical genetic counseling, higher education, industry, and consulting. Matt’s professional interests include prenatal genetics; artificial intelligence; academic and industry partnerships; and multi-state licensure.
-
Register
- Non-member - $50
- Member - Free!
- More Information
-
Register
-
Contains 1 Component(s) Includes a Live Web Event on 10/07/2026 at 12:00 PM (CDT)
In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.
Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will present challenging cases, including a prenatal whole exome sequencing workup that led to variant reclassification, cascade testing across an extended family, and unexpected management implications for the pregnant patient; a rare prenatal skeletal dysplasia case complicated by unexpected parental carrier testing results; and a family undergoing repeated diagnostic and counseling shifts as new genetic evidence challenged established disease expectations. Together, these cases highlight evolving genetic knowledge, complex result interpretation, nuanced risk assessment, and the counseling strategies needed to support patients and families facing uncertainty.
Presented by:
1. Nour Chanouha, MS, CGC
2. Olivia Kessler, MS, LCGC
3. Hannah S. Anderson, MS, CGCLearning Objectives:
1. Evaluate a prenatal genetics case with unexpected results and the implications on recurrence risk and next steps.
2. Evaluate complex genetic results disclosure plans based on multiple clinical and psychosocial factors.$i++ ?>
Nour Chanouha, MS, CGC
Nour Chanouha has been practicing as a genetic counselor at the University of Iowa Healthcare since 2022 and sees patients in both the fetal diagnosis and treatment center and the reproductive endocrinology and IVF clinics. She is a board member of the Arab Society of Genetic Counselors and the co-Chair of its Education Committee and is the co-Chair of the Mentorship subcommittee of the International SIG at NSGC. She is also an active volunteer on different committees of the American Society for Reproductive Medicine, the Society for Assisted Reproductive Technology and NSGC. Nour has published research work advocating for the expansion of genetic counseling globally and the inclusion of the practice of logotherapy in genetic counseling, among others.
$i++ ?>
Hannah S. Anderson, MS, CGC
Hannah Anderson graduated from the Indiana University Genetic Counseling Program in 2016. Over the past 10 years, she has held a variety of roles in the field, including clinical, laboratory, and program leadership positions. She is currently the lead genetic counselor at the Children’s Hospital Colorado Heart Institute, where she sees patients with congenital and childhood-onset heart conditions, pulmonary hypertension, vascular anomalies, and HHT in both inpatient and outpatient settings.
$i++ ?>
Olivia Kesler, MS, LCGC
Olivia is a certified genetic counselor. Originally from Columbus, Mississippi, she is a 2020 graduate of the University of South Carolina’s Genetic Counseling Training Program. She has worked as a genetic counselor at the University of Alabama at Birmingham for the past six years, practicing in both cancer and prenatal genetics.
-
Register
- Non-member - $50
- Member - Free!
- More Information
-
Register
-
Contains 1 Component(s) Includes a Live Web Event on 09/30/2026 at 12:00 PM (CDT)
Presented by the NSGC Skeletal Dysplasia SIG
Prenatal skeletal dysplasias are among the most challenging conditions to diagnose and counsel prenatally due to variable phenotypic expression, evolving genotype-phenotype correlations, and limitations of prenatal imaging and molecular testing. While advances in genomic technologies have improved diagnostic capabilities, predicting clinical outcomes, including survival, severity, and long-term prognosis, often remains uncertain.
This webinar will review current approaches to the prenatal evaluation of suspected skeletal dysplasias and explore the challenges of prognostication in the context of uncertain or evolving information. Through clinical cases, participants will examine practical counseling strategies for communicating uncertainty, supporting informed decision-making, and providing patient-centered care for families navigating complex prenatal diagnoses of skeletal dysplasia.
Presented by:
NSGC Skeletal Dysplasia SIG
1. Shannon Persick, MS, CGCLearning Objectives:
1. Review the most common prenatal presentations of skeletal dysplasias.
2. Describe the major factors that contribute to prognostic uncertainty in prenatal skeletal dysplasia evaluation, including limitations of ultrasound examination, molecular testing, and genotype phenotype correlations.
3. Illustrate the spectrum of clinical outcomes associated with prenatal skeletal dysplasia diagnoses through real-life case examples.
4. Recognize common psychosocial challenges experienced by families navigating a new diagnosis of skeletal dysplasia in both the prenatal and neonatal periods.$i++ ?>Shannon Persick, MS, CGC
Shannon Persick is a genetic counselor serving with the multidisciplinary Skeletal Dysplasia and Osteogenesis Imperfecta Clinics at Nemours Children's Hospital in Wilmington, Delaware. In this role, she partners with patients and families from the prenatal period through adulthood as they navigate new diagnoses and various aspects of life with a skeletal dysplasia. Prior to this position, she specialized in reproductive genetics at a large tertiary fetal care center. Drawing on her experience in both prenatal and specialty skeletal dysplasia care, she is particularly passionate about improving prognostic communication and providing compassionate, family-centered support for those navigating a prenatal diagnosis of skeletal dysplasia.
-
Register
- Non-member - $50
- Member - Free!
- More Information
-
Register
-
Contains 4 Component(s), Includes Contact Hours
In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.
Advancements in genomic knowledge and next generation sequencing technologies have resulted in expanded carrier screening creating more equitable opportunities for individuals to learn about their reproductive risks for various genetic conditions including inherited eye and hearing conditions. For many of the ocular and auditory conditions included in carrier screening panels there are wide spectrums of phenotypic features including age of onset and severity. In this webinar, we discuss some common carrier screening findings for ocular and auditory conditions and offer strategies for providing a nuanced approach to genetic counseling about ocular and auditory conditions.
Presented by:
NSGC Ophthalmology and Hearing Loss SIG
1. Shay Guetz-Lindahl, MS, CGC
2. Emily Place, MS, LCGCLearning Objectives:
1. Define the spectrum of presentation of ocular genetic conditions found on carrier screening.
2. Define the spectrum of presentation of hearing loss genetic conditions on carrier screening.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Spectrum of Senses: Insights and Caveats for navigating ocular and auditory genetics in prenatal and preconception counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluationContent expires December 31, 2027.
-
Register
- Non-member - $50
- Member - $35
- More Information
-
Register
-
Contains 18 Product(s) 1 new product(s) added recently
This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.
This all-inclusive package offers access to the full set of 24 webinars from NSGC’s 2026 Webinar Series, complete with CEUs. Please note that webinars will be added to this package as they are released.
To purchase the 2026 NSGC Webinar Series Full Package, click the blue "Register Now" button next to the package title. Do not register for the individual components included in the package.
Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to 2.4 CEUs or 24 Category 1 contact hours for the 2026 NSGC Webinar Series Full Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.-
Register
- Non-member - $475
- Member - $400
- More Information
-
Register
-
Contains 4 Component(s), Includes Contact Hours
This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings.
This webinar examines how genetic counselors are implementing pharmacogenomics (PGx) testing and counseling across healthcare settings. Over 95% of the population carries clinically significant pharmacogene variants, yet implementation lags behind other genetic testing due to limited workforce training, provider literacy gaps, and high clinical decision support costs. The presenters showcased three primary PGx service delivery models: academic medicine programs (Brigham & Women's Hospital telemedicine clinic and M Health Fairview's Go4PGx Initiative), private practice collaborations between genetic counselors and pharmacists, and laboratory-based models such as Color Health's integration with cancer clinics and research partnerships. Future challenges include managing increasingly complex sequencing-based and polygenic score PGx results while capitalizing on opportunities from long-read genomics and rapid sequencing technologies. Training programs and continuing education must expand to meet growing clinical integration of PGx and establish counselor competency as a hiring differentiator.
Presented by:
NSGC Precision Medicine SIG
1. Hannah Llorin, MS, CGC
2. Elizabeth Fieg, MS, CGC
3. Hetanshi Naik, PhD, MS, CGC
4. Jen Eichmeyer, MS, CGC
5. Jeri Nichols, MS, PharmD, CGC, CSP
6. Carla McGruder, MS, CGC
7. Rissa Hall, MS, CGCLearning Objectives:
1. Explain the clinical relevance and utility of pharmacogenomics (PGx)
2. Identify barriers to PGx implementation in genetic counseling practice and recognize emerging opportunities to advance the field
3. Compare genetic counselor roles and responsibilities across academic, private practice, and laboratory-based PGx modelsGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, From Niche to Necessary: Genetic Counselor-Led Pharmacogenomics Across the Care Continuum. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation-
Register
- Non-member - $50
- Member - $35
- More Information
-
Register
-
Contains 4 Component(s), Includes Contact Hours
This webinar meets GCs where they are—not with a generic leadership curriculum, but with a peer-to-peer conversation grounded in real role transitions within the genetics and diagnostics space.
Genetic counselors are increasingly moving into roles in industry, diagnostics, digital health, research, and consulting—positions where leadership happens through influence, expertise, and strategic relationships rather than formal management. Yet professional development resources for GCs tend to focus on either clinical skill-building or early-career milestones. There is a gap in programming that speaks to:
• GCs who have led teams and are navigating a shift to peer-level influence
• GCs in industry or commercial roles who must lead without direct reports
• GCs asking how to articulate and leverage their leadership experience when a title change obscures it
• GCs at any stage wondering whether leadership is still part of their identity when the structure changes
This webinar meets GCs where they are—not with a generic leadership curriculum, but with a peer-to-peer conversation grounded in real role transitions within the genetics and diagnostics space.
Presented by:
NSGC Leadership and Management SIG
1. Kelly Tangney, MS, CGCLearning Objectives:
1. Distinguish between positional leadership (authority-based) and relational leadership (influence-based), and identify which model applies to your current role.
2. Recognize the leadership and management competencies you have already developed, and articulate how those competencies transfer across role types.
3. Apply at least two concrete strategies for leading effectively among peers and cross-functional partners without direct authority.
4. Describe how role transitions can lead to leadership evolution across role types.
5. Identify your next steps for continued professional growth as a leader, regardless of title or organizational structure.Genetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Leading Without the Title: How Genetic Counselors Can Navigate Leadership Across Changing Roles. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation-
Register
- Non-member - $50
- Member - $35
- More Information
-
Register
-
Contains 4 Component(s), Includes Contact Hours
In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.
Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.
Presented by:
1. Chenery Lowe, ScM, CGC, PhD
2. Lauren Puryear, MS, CGC
3. Brittany Sears, PhD, MSPH, LCGCLearning Objectives:
1. Identify patient’s stated and unstated goals for genetic testing.
2. Design a genetic testing strategy that meets both patient’s stated and unstated goals.
3. Identify strategies to navigate ethical conflicts regarding personal autonomy, disclosure timelines, and parental authority when managing genetic testing without assent in pediatric populations.
4. Determine ethically permissible options for reproductive decisions informed by reproductive, disability, and professional ethics frameworksGenetic Counselor CEUs:
The National Society of Genetic Counselors (NSGC) has authorized the National Society of Genetic Counselors (NSGC) to offer up to .1 CEUs or 1 Category 1 contact hour for the activity, Case Based Webinar - Part III. The American Board of Genetic Counseling (ABGC) will accept CEUs earned by participating in this program for the purposes of genetic counselor recertification.
Successful Completion:
1. View recording
2. Pass quiz
3. Complete evaluation-
Register
- Non-member - $50
- Member - $35
- More Information
-
Register